Published on: January 30, 2019 at 12:00PM
Condition: Prostate Cancer
Interventions: Drug: CTT1403; Drug: CTT1057 or 68Ga-PSMA-11
Sponsors: Cancer Targeted Technology; University of California, San Francisco
Not yet recruiting
http://bit.ly/2RY2qmt
No comments:
Post a Comment